Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
McKesson Corporation
MCK | US
931.35
USD-47.36
-4.84%
MCK | US
About McKesson Corporation
Sector
Healthcare
Industry
Medical Distribution
Earnings date
30/06/2024
As of date
05/03/2026
Close
931.35
Open
948.10
High
948.38
Low
920.04
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical Prescription Technology Solutions (RxTS) Medical-Surgical Solutions and International. The U.S. Pharmaceutical segment distributes branded generic specialty biosimilar and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management technology clinical support and business solutions to community-based oncology and other specialty practices; and consulting outsourcing technological and other services as well as sells financial operational and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients pharmacies providers pharmacy benefit managers health plans and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency benefit insight dispensing support third-party logistics and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution logistics and other services to healthcare providers including physician offices surgery centers nursing homes hospital reference labs and home health care agencies. The International segment offers distribution and services to wholesale institutional and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving Texas.
View LessMCK | US
Risk
64.6
Sharpe
1.40
Luna's Score
60/100
Recommendation
Hold
Luna says (MCK | US)
What's Working
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Sharpe Ratio (> 1.2)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
28.9%1 month
64.6%3 months
39.9%6 months
33.5%Returns
Fundamental Ratios
PE
22.75
Fwd. PE
15.95
Price to book
5.04
Debt to equity
-4.21
Debt to assets
0.10
Ent. to EBITDA
15.10
Ent. to rev.
0.23
PEG
1.48
Other Fundamentals
EBITDA
5.14B
MarketCap
120.77B
MarketCap(USD)
120.77B
Div. yield
0.56
Op. margin
1.45
Erngs. growth
-0.30
Rev. growth
6.40
Ret. on equity
-
Short ratio
1.79
Short perc.
1.85
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
78.96
Range1M
181.83
Range3M
209.04
Volumes: Market Activity
Rel. volume
1.64
Price X volume
1.38B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 15.10 | 10.10 | Expensive |
| Ent. to Revenue | 0.23 | 14.76 | Cheaper |
| PE Ratio | 22.75 | 22.15 | Par |
| Price to Book | 5.04 | 4.41 | Par |
| Dividend Yield | 0.56 | 2.46 | Poor |
| Std. Deviation (3M) | 39.87 | 45.77 | Par |
| Debt to Equity | -4.21 | 0.16 | Cheaper |
| Debt to Assets | 0.10 | 0.25 | Cheaper |
| Market Cap | 120.77B | 16.61B | Market Leader |
